Patient Care

Wilmot Cancer Institute Earns Prestigious Designation from the National Cancer Institute

Mar. 18, 2025
The distinction places Wilmot in the top 4 percent of all cancer centers in the United States
The National Cancer Institute (NCI) has named the University of Rochester Wilmot Cancer Institute as the nation’s 73rd designated cancer center. The distinction places the institute in the top 4 percent of all cancer centers in the United States.
Wilmot NCI Designation Team

In a press conference earlier today, Wilmot Cancer Institute Director Jonathan Friedberg, University of Rochester President Sarah Mangelsdorf, University of Rochester Medical Center CEO David Linehan, and Congressman Joseph Morelle marked the historic day. City of Rochester Mayor Malik Evans, Monroe County Executive Adam Bello, and representatives from several state and federal elected officials were also in attendance to celebrate Wilmot and this new NCI designation.

With this designation, Wilmot joins an elite class of centers that have been through a rigorous evaluation process and selected to be at the forefront of research, community engagement, education and training, and life-saving care in the U.S. NCI designation comes with $10 million in funding over five years to expand patient access to clinical trials and develop new research initiatives.